The Smartest Investors Club
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Smartest Investors Club

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
House vote imminent on Trump-backed bill to avoid government shutdown
next post
Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

You may also like

Endeavour Achieves First Gold Pour at Sabodala-Massawa Expansion

Top 5 Canadian Mining Stocks This Week: American...

Uranium Stocks: 5 Biggest Companies in 2023

Riverside Resources and Fortuna Mining Progress with Phase...

Top 5 NASDAQ Biotech Stocks

FPX Nickel Expands Land Packages at the Decar...

Beyond Lithium

Trident Royalties PLC Announces Court Sanction of Scheme...

Forum Energy Metals

Baselode to Begin Bear Uranium Project Drill Program...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Iran has amassed even more near weapons-grade uranium, UN watchdog says

    • UK to ban sale of disposable vapes in response to soaring waste and safety risks

    • ISIS claims first attacks against forces loyal to new government in Syria

    • ‘A fear campaign.’ Students around the world are shocked, scared and saddened by US visa pause

    • North Korea deploys mystery balloon-like objects to stricken warship, satellite photos show

    Categories

    • Business (1,673)
    • Investing (4,999)
    • Politics (7,837)
    • World (6,352)
    • Terms & Conditions
    • Privacy Policy
    • About us

    Disclaimer: thesmartestinvestorsclub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 thesmartestinvestorsclub.com | All Rights Reserved


    Back To Top